Genmark Diagnostics reported $-460000 in EBITDA for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 2366M 678M
Agilent A:US $ 435M 40M
Bruker BRKR:US $ 111.2M 4.2M
Danaher DHR:US $ 2530M 31M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Hologic HOLX:US $ 463.4M 415.5M
Illumina ILMN:US $ 236M 5M
Laboratory Of America LH:US $ 937.1M 335.4M
Luminex LMNX:US $ 21.3M 3.09M
Mesa Laboratories MLAB:US $ 7.69M 1.42M
Myriad Genetics MYGN:US $ -2.1M 26.2M
Nanostring Technologies NSTG:US $ -24.2M 0.23M
Oxford Immunotec Global OXFD:US $ 0.79M 10.16M
Perkinelmer PKI:US $ 398.96M 158.86M
Quest Diagnostics DGX:US $ 654M 128M
Quidel QDEL:US $ 38.82M 198.8M
Siemens SIE:GR € 2577M 193M
Thermo Fisher Scientific TMO:US $ 2942M 766M
Veracyte VCYT:US $ 5.73M 13.49M
Waters WAT:US $ 229.24M 26.61M